title: Metachronous ovarian metastases following resection of the primary gastric cancer.
abstract: OBJECTIVE
  We performed this study to evaluate the clinical presentation as well as the proper surgical intervention for ovarian metastasis from gastric cancers and these tumors were identified during postoperative follow-up. This will help establish the optimal strategy for improving the survival of patients with this entity.
  
  
  METHODS
  22 patients (3.2%) with ovarian metastasis were noted when performing a retrospective chart review of (693) females patients who had undergone a resection for gastric cancer between 1981 and 2008. The covariates used for the survival analysis were the patient age at the time of ovarian relapse, the size of the tumor, the initial TNM stage of the gastric cancer, the interval to metastasis and the presence of gross residual disease after treatment for Krukenberg tumor. The cumulative survival curves for the patient groups were calculated with the Kaplan-Meier method and they were compared by means of the Log-Rank test.
  
  
  RESULTS
  The average age of the patients was 48.6 years (range: 24 to 78 years) and the average survival time of the 22 patients was 18.8 months (the estimated 3-year survival rate was 15.8%) with a range of 2 to 59 months after the diagnosis of Krukenberg tumor. The survival rate for patients without gross residual disease was longer than that of the patients with gross residual disease (P=0.0003). In contrast, patient age, the size of ovarian tumor, the initial stage of gastric adenocarcinoma, the interval to metastasis and adjuvant chemotherapy were not prognostic indicators for survival after the development of ovarian metastasis.
  
  
  CONCLUSIONS
  Early diagnosis and complete resection are the only possible hope to improve survival. As the 3-year survival rate after resection of Krukenberg tumor is 15.8%, it seems worthwhile to consider performing tumorectomy as the second cytoreduction.
authors.affiliation: Department of Surgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
authors.forename: Si-Youl
authors.initials: SY
authors.lastname: Jun
authors.forename: Jong Kwon
authors.initials: JK
authors.lastname: Park
references.citation: Gynecol Oncol. 2001 Jul;82(1):105-9
references.pmid: 11426970
references.citation: Eur J Gastroenterol Hepatol. 2009 Aug;21(8):855-60
references.pmid: 19369882
references.citation: J Gastroenterol. 2003;38(12):1176-80
references.pmid: 14714257
references.citation: Am J Surg Pathol. 2006 Mar;30(3):277-99
references.pmid: 16538048
references.citation: Oncology. 2004;67(1):19-26
references.pmid: 15459491
references.citation: J Clin Oncol. 2006 Jun 20;24(18):2903-9
references.pmid: 16782930
references.citation: Chirurgia (Bucur). 2008 Jan-Feb;103(1):23-38
references.pmid: 18459494
references.citation: Gynecol Oncol. 2004 Aug;94(2):477-82
references.pmid: 15297191
references.citation: Abdom Imaging. 2007 Nov;32(6):784-95
references.pmid: 17318680
references.citation: J Clin Oncol. 2010 May 10;28(14):2430-6
references.pmid: 20368551
references.citation: Gynecol Oncol. 2003 May;89(2):314-7
references.pmid: 12713997
references.citation: Prim Care Update Ob Gyns. 1998 Jul 1;5(4):157-158
references.pmid: 10838292
references.citation: Gynecol Oncol. 2002 Oct;87(1):77-83
references.pmid: 12468346
references.citation: Br J Surg. 2000 Feb;87(2):236-42
references.pmid: 10671934
references.citation: Gynecol Obstet Invest. 1999;48(1):61-5
references.pmid: 10394095
references.citation: Am J Surg Pathol. 2006 Nov;30(11):1382-8
references.pmid: 17063077
references.citation: Int J Gynecol Cancer. 2008 Jul-Aug;18(4):825-32
references.pmid: 17892453
references.citation: Chirurg. 1993 Dec;64(12):1040-3
references.pmid: 8119090